Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

T0070907 (CAS 313516-66-4)

5.0(1)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
2-chloro-5-nitro-N-4-pyridinyl-benzamide
Application:
T0070907 is a cell-permeable chloro-nitro-benzamido compound that acts as a potent and specific antagonist of PPARg
CAS Number:
313516-66-4
Purity:
>97%
Molecular Weight:
277.7
Molecular Formula:
C12H8ClN3O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

T0070907 is a widely utilized organochlorine compound in scientific research, offering potential applications in various fields such as pharmacodynamics, and more. This cell-permeable chloro-nitro-benzamido compound acts as a potent, specific, irreversible, and high-affinity antagonist of PPARγ, displaying a Ki value of 1 nM. It exhibits remarkable selectivity for PPARγ over PPARα and PPARδ (Ki values of 0.85 μM and 1.8 μM, respectively). T0070907 effectively impedes hormone- and agonist-induced adipogenesis in 3T3-L1 cells, blocking interactions between PPARγ and coactivator-derived peptides while facilitating recruitment of corepressor-derived peptides. Through covalent binding to Cys313 in the ligand-binding domain, it modulates the interaction of PPARγ2 with cofactor proteins. The inhibitory potential of T0070907 has been investigated against various bacteria, including E. coli and S. aureus, as well as several fungi, such as Candida albicans and Aspergillus flavus. Moreover, studies have explored its capacity to impede tumor cell growth in mice, alongside anti-inflammatory and antioxidant properties. Although the precise mechanism of action of T0070907 remains under investigation, it is postulated that this compound exerts its biological activity by binding to specific proteins on the cell membrane, thereby impeding cellular growth and proliferation.


T0070907 (CAS 313516-66-4) References

  1. Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia.  |  Collin, M., et al. 2006. Crit Care Med. 34: 1131-8. PMID: 16484917
  2. The microtubule-targeting agent T0070907 induces proteasomal degradation of tubulin.  |  Harris, G. and Schaefer, KL. 2009. Biochem Biophys Res Commun. 388: 345-9. PMID: 19665001
  3. The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.  |  Zaytseva, YY., et al. 2011. Anticancer Res. 31: 813-23. PMID: 21498701
  4. Peroxisome proliferator-activated receptor γ (PPARγ)-independent specific cytotoxicity against immature adipocytes induced by PPARγ antagonist T0070907.  |  Kawahara, A., et al. 2013. Biol Pharm Bull. 36: 1428-34. PMID: 23995653
  5. T0070907, a PPAR γ inhibitor, induced G2/M arrest enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe.  |  An, Z., et al. 2014. Reprod Sci. 21: 1352-61. PMID: 24642720
  6. T0070907 inhibits repair of radiation-induced DNA damage by targeting RAD51.  |  An, Z., et al. 2016. Toxicol In Vitro. 37: 1-8. PMID: 27544453
  7. Aspirin Ameliorates Preeclampsia Induced by a Peroxisome Proliferator-Activated Receptor Antagonist.  |  Zhang, C., et al. 2018. Reprod Sci. 25: 1655-1662. PMID: 29439623
  8. Antagonizing peroxisome proliferator-activated receptor γ facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway.  |  Ji, J., et al. 2018. Aging Cell. 17: e12774. PMID: 29740932
  9. MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-γ-mediated PI3K/AKT signaling.  |  Chen, T., et al. 2019. Aging (Albany NY). 11: 7510-7524. PMID: 31562809
  10. Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats.  |  Li, L., et al. 2021. Int Immunopharmacol. 92: 107335. PMID: 33429332
  11. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.  |  Xing, L., et al. 2021. Life Sci. 269: 119068. PMID: 33476631
  12. Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.  |  Yang, S., et al. 2021. Biomed Pharmacother. 138: 111441. PMID: 33652261
  13. Phthalate monoesters act through peroxisome proliferator-activated receptors in the mouse ovary.  |  Meling, DD., et al. 2022. Reprod Toxicol. 110: 113-123. PMID: 35421560

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

T0070907, 5 mg

sc-203287
5 mg
$141.00